Related Experiment Video
Updated: May 15, 2026
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Stroke risk stratification scores in atrial fibrillation: current recommendations for clinical practice and future
Joseph Durrant1, Gregory Y H Lip, Deirdre A Lane
1University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Dudley Road, Birmingham, B18 7QH, UK.
Insights
Atrial fibrillation (AF) stroke risk stratification scores (RSS) help identify patients needing oral anticoagulants (OAC). Current guidelines use CHA₂DS₂-VASc, but novel OACs may alter treatment thresholds.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Background:
- Atrial fibrillation (AF) significantly elevates stroke risk.
- Clinical risk factors influence this heightened stroke risk, though some factors' contributions are debated.
- Stroke risk stratification scores (RSS) are crucial for assessing AF-related stroke risk.
Purpose of the Study:
- To evaluate the role of RSS in guiding oral anticoagulant (OAC) therapy for stroke prevention in AF patients.
- To discuss how current guidelines and emerging OACs impact OAC treatment decisions.
- To highlight the importance of balancing stroke risk reduction with bleeding risk and patient preferences.
Main Methods:
- Review of current guidelines and risk stratification scores (RSS) for AF stroke risk assessment.
- Analysis of the impact of clinical risk factors on stroke risk in AF.
- Consideration of the evolving landscape with novel oral anticoagulants (NOACs).
Main Results:
- The CHA₂DS₂-VASc score is the current standard for stratifying stroke risk in AF.
- It helps identify low-risk patients who may not need antithrombotic therapy.
- Novel OACs may necessitate adjustments to the risk thresholds for initiating therapy.
Conclusions:
- RSS are essential for optimizing OAC use in AF, maximizing benefits while minimizing harms.
- Treatment decisions must consider stroke risk, bleeding risk, and patient preferences.
- The advent of NOACs necessitates a re-evaluation of current stroke risk stratification and treatment paradigms in AF.
Abstract:
Atrial fibrillation (AF) increases the risk of stroke. This additional risk varies depending on the presence of various clinical risk factors. The contribution of some risk factors, for example vascular disease and female gender, has been disputed. Stroke risk stratification scores (RSS) incorporate these risk factors to identify patients at different levels of stroke risk. These RSS enable the targeting of oral anticoagulants (OAC) at high-risk patients, who stand to gain the most in terms of stroke risk reduction, and avoidance of their use in low-risk patients, in whom the harms of OAC (increased risk of bleeding) may outweigh their stroke prevention capabilities. Guidelines on the management of AF have used and adapted various RSS for this purpose, and have tailored their therapeutic recommendations around the different risk categories. Current guidelines advocate the use of the CHA₂DS₂-VASc RSS to assess stroke risk in AF patients, to identify truly low-risk patients (men and women aged <65 years with no risk factors) who may not require antithrombotic therapy, with consideration of OAC for all other patients. The recent development of novel OACs is changing the risk threshold at which it is acceptable to treat AF patients. However, consideration of OAC therapy for stroke prevention also requires assessment of the associated bleeding risk and incorporation of patients' preferences when making treatment decisions.
More Related Videos
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:26Atherosclerosis III: Management
01:23Atherosclerosis IV: Nursing Management
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications